Molecularly targeted therapy for the treatment of head and neck cancer: a review of the ErbB family inhibitors

Molecularly targeted therapy for the treatment of head and neck cancer: a review of the ErbB family inhibitors

Assuntina G Sacco,1 Francis P Worden2 1Department of Internal Medicine, Division of Hematology/Oncology, University of California at San Diego Moores Cancer Center, La Jolla, CA, USA; 2Department of Internal Medicine, Division of Hematology/Oncology, University of Michigan Health System, Ann Arbor,...

Full description

Bibliographic Details
Main Authors: Sacco AG, Worden FP
Format: Article
Language:English
Published: Dove Medical Press 2016-04-01
Series:OncoTargets and Therapy
Subjects:
head and neck cancer
epidermal growth factor receptor
monoclonal antibody
tyrosine kinase inhibitor
Online Access:https://www.dovepress.com/molecularly-targeted-therapy-for-the-treatment-ofnbsphead-and-neck-can-peer-reviewed-article-OTT

Internet

https://www.dovepress.com/molecularly-targeted-therapy-for-the-treatment-ofnbsphead-and-neck-can-peer-reviewed-article-OTT

Similar Items